In Vivo Evaluation of Antidiarrhoeal Activity of the Seed of Swietenia macrophylla King (Meliaceae)
Purpose: The seeds of Swietenia macrophylla are used in traditional medicine for the treatment of diarrhoea. Thus the petroleum ether extract of Swietenia macrophylla (Meliaceae) seeds was investigated for its anti-diarrhoeal property in Wister albino rats to substantiate folklore claim. Methods: Petroleum ether extract of the seeds of this plant, at graded doses (25, 50 & 100mg/kg body weight) was investigated for anti-diarrhoeal activity in term of reduction in the rate of defecation and consistency of faeces in castor oil induced diarrhoea. To understand the mechanism of its anti-diarrhoeal activity, its effect was further evaluated on intestinal transit and castor oil induced intestinal fluid accumulation (enteropooling). Results: At various doses (25, 50 & 100mg/kg body weight) the extract showed a remarkable anti-diarrhoeal activity evidenced by the reduction in the rate of defecation and consistency of faeces. Results are comparable to that of standard drug diphenoxylate (50mg/kg body weight). A single oral dose of Swietenia macrophylla extract of 100mg/kg body weight produced a significant decrease in the severity of diarrhoea. Extract produced profound decrease in intestinal transit (4.45 - 34.60%) also significantly inhibited castor oil induced enteropooling comparable to that of intraperitoneal injection of standard drug atropine sulphate at doses of 0.1 mg/kg body weight and 3 mg/kg body weight respectively. Conclusions: Experimental findings showed that petroleum ether extract of seeds of Swietenia macrophylla possess significant anti-diarrhoeal activity and may be a potent source of anti-diarrhoeal drug in future.
Keywords: Swietenia macrophylla, anti-diarrhoeal activity, castor oil, atropine sulphate.
> Tropical Journal of Pharmaceutical Research Vol. 6 (2) 2007: pp. 711-716
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.